HealthEquity, Inc. (NASDAQ:HQY) is Summit Creek Advisors LLC’s 6th Largest Position

Summit Creek Advisors LLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY) by 6.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 239,696 shares of the company’s stock after selling 16,635 shares during the quarter. HealthEquity comprises 2.8% of Summit Creek Advisors LLC’s investment portfolio, making the stock its 6th largest holding. Summit Creek Advisors LLC owned approximately 0.28% of HealthEquity worth $20,662,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Cape Investment Advisory Inc. bought a new stake in shares of HealthEquity during the 4th quarter valued at about $27,000. Rise Advisors LLC bought a new stake in shares of HealthEquity during the 1st quarter valued at about $28,000. International Assets Investment Management LLC bought a new stake in shares of HealthEquity during the 2nd quarter valued at about $35,000. YHB Investment Advisors Inc. bought a new stake in shares of HealthEquity during the 1st quarter valued at about $40,000. Finally, Fidelis Capital Partners LLC bought a new stake in shares of HealthEquity during the 1st quarter valued at about $42,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the subject of a number of research analyst reports. Raymond James lifted their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Friday, June 7th. KeyCorp raised their price objective on HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a report on Wednesday, June 5th. Barrington Research reissued an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a report on Friday, August 30th. Deutsche Bank Aktiengesellschaft raised their price objective on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday. Finally, JMP Securities reissued a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a report on Wednesday. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $103.83.

HealthEquity Trading Down 3.8 %

NASDAQ HQY opened at $79.49 on Friday. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44. HealthEquity, Inc. has a twelve month low of $61.81 and a twelve month high of $88.26. The firm has a market capitalization of $6.92 billion, a PE ratio of 86.40, a P/E/G ratio of 1.34 and a beta of 0.52. The stock’s 50 day moving average is $77.23 and its 200 day moving average is $79.70.

HealthEquity (NASDAQ:HQY) last released its earnings results on Monday, June 3rd. The company reported $0.55 EPS for the quarter, topping the consensus estimate of $0.47 by $0.08. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. The business had revenue of $287.60 million for the quarter, compared to the consensus estimate of $278.78 million. Research analysts forecast that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the business’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the business’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the sale, the director now directly owns 6,070 shares in the company, valued at $497,072.30. The disclosure for this sale can be found here. Over the last three months, insiders have sold 75,031 shares of company stock valued at $6,103,625. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.